Saturday, April 06, 2019 3:19:19 PM
JMMA, very good post in my view. And, contributing your experiences with Delcath in a responsible manner is the best thing you can do to keep others from falling into the same situation you find yourself in today.
You do have to keep in mind that many of the posters here are "traders" flipping for a few pennies and not true "longs" or "bulls" as they claim to be.
After being invested for over 2 years now I am not holding out much hope for a reversal in Delcath especially since they have missed the filing deadline and are now subject to a variety of costly penalties, including deregistration by the SEC, delisting to the "Grey" market by the OTC and most importantly, the inability to raise capital through issuance of public securities, and potential debt covenant violations.
As Delcath failed to file for an extension, they are not eligible to issue securities using Form S-3 until they have filed in a timely manner for at least 12 months according to current rules. This in itself will severely limit their abilty to raise the capital they need to continue as a going concern.
So, unless they have a "white knight" in their pocket with a lot of cash on hand or some other "magic trick" up their sleeve, I would be expecting to see a filing for bankruptcy in the very near future.
Trade Safe.
You do have to keep in mind that many of the posters here are "traders" flipping for a few pennies and not true "longs" or "bulls" as they claim to be.
After being invested for over 2 years now I am not holding out much hope for a reversal in Delcath especially since they have missed the filing deadline and are now subject to a variety of costly penalties, including deregistration by the SEC, delisting to the "Grey" market by the OTC and most importantly, the inability to raise capital through issuance of public securities, and potential debt covenant violations.
As Delcath failed to file for an extension, they are not eligible to issue securities using Form S-3 until they have filed in a timely manner for at least 12 months according to current rules. This in itself will severely limit their abilty to raise the capital they need to continue as a going concern.
So, unless they have a "white knight" in their pocket with a lot of cash on hand or some other "magic trick" up their sleeve, I would be expecting to see a filing for bankruptcy in the very near future.
Trade Safe.
Anything written herein that you find misspelled, objectionable, incoherent, dim-witted, plagiarized or legally actionable should be attributed to the keyboard Manufacturer, Russian Hackers, Jack Daniels (the drink not the person) or the DNC.
Recent DCTH News
- Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference • Business Wire • 05/12/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 01:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 12:12:12 PM
- Delcath Systems Reports First Quarter 2026 Results and Business Highlights • Business Wire • 05/07/2026 12:00:00 PM
- Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 • Business Wire • 05/07/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Delcath Systems to Host First Quarter 2026 Earnings Call • Business Wire • 04/23/2026 12:30:00 PM
- Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma • Business Wire • 04/06/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 12:56:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 12:55:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 12:52:52 PM
- Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting • Business Wire • 04/01/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:22:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:48:16 PM
- Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology • Business Wire • 03/03/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 02:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:06:06 PM
- Delcath Systems Reports Fourth Quarter and Full Year 2025 Results • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:30:05 AM
